There are 2,426 papers on Short Physical Performance Battery in aging research: 654 trials and 1,476 observational studies in people, 166 reviews. The newest story, Nov 13, 2026: “Cuff-assisted exercise linked to better blood pressure”.
Exercise showed no clear effect on Short Physical Performance Battery in humans (rheumatoid arthritis at high risk of sarcopenia) (difference 0.2 points, 95% CI -0.1 to 0.5, p = 0.206).
“The 16-week personalized exercise therapy did not improve the total SPPB scores.”
Human trialrheumatoid arthritis at high risk of sarcopenia16-weekn = 134
Exercise improves Short Physical Performance Battery in humans (+1.09 points (3 days), +1.97 points (4 days), +2.02 points (5-7 days), p < .001).
“Exercise groups increased SPPB scores compared with controls, with gains of 1.09 points after three days, 1.97 points after four days, and 2.02 points after 5-7 days (p < .001).”
Exercise showed no clear effect on Short Physical Performance Battery in humans (mean difference 0.5 points, 95% CI [-0.6, 1.5]).
“There was no statistically significant between-group difference in the Short Physical Performance Battery (mean difference 0.5 points, 95% confidence interval [-0.6, 1.5], p = .378).”
Exercise showed no clear effect on Short Physical Performance Battery in humans after hip fracture, in addition to usual care during short-term nursing home stay.
“No statistically significant differences between groups was found in any outcomes after 2 weeks or 3 months (p > 0.05).”
Human trialafter hip fracture, in addition to usual care during short-term nursing home stayup to four times a day, 7 days a week2 weeksn = 140
Physical activity improves Short Physical Performance Battery in humans (history of cancer) (0.45 points (95% CI, 0.05-0.86) at 6 months; 0.43 (0.02-0.83) at 12 months; 0.45 (0.04-0.87) at 24 months).
“Randomization to physical activity, compared with health education, improved the SPPB score at 6 months (0.45 points [95% confidence interval (CI), 0.05-0.86]; p = .027)”
Physical activity showed no clear effect on Short Physical Performance Battery in humans (older adults with lymphoma or carcinoma) (14.0% UCG vs 18.7% IG).
“After 1 year, 14.0% of participants in the UCG and 18.7% in the IG had a decrease in SPPB score of 1 point or more (P = 0.772).”
Human trialolder adults with lymphoma or carcinomaindividualized telephone-delivered physical activity advice1 yearn = 301
Physical activity is linked with less Short Physical Performance Battery in humans (mostly active vs mostly inactive over 3 years) (-1.08 (95% CI -1.43 to -0.73) vs -2.60 (95% CI -2.92 to -2.27)).
“being mostly active (-1.08, 95% confidence interval (CI) = -1.43 to -0.73) and minimally active (-1.33, 95% CI = -1.53 to -1.12) over 3 years of follow-up was associated with less decline in SPPB score than being mostly inactive (-2.60, 95% CI = -2.92 to -2.27)”
Humansmostly active vs mostly inactive over 3 years9 yearsn = 782
The journals of gerontology. Series A, Biological sciences and medical sciences·
Resistance training improves Short Physical Performance Battery in humans (frail and prefrail patients with type 2 diabetes) (+36.1% at week 18 (P < .001)).
“Each set of 16 weeks of intervention resulted in significant improvements in SPPB performance by a mean of 36.1% at week 18 (P < .001)”
Human trialfrail and prefrail patients with type 2 diabetes18 weeksn = 52
Journal of the American Medical Directors Association·
Resistance training improves Short Physical Performance Battery in humans (older, obese persons with sarcopenia) (13%).
“After training, participants in the SAR group were able to significantly increase their performance in hand-grip strength (by 9%), gait speed (by 5%), SPPB score (by 13%), and modified PPT score (by 11%).”
Human trialolder, obese persons with sarcopeniaprogressive resistance trainingtwice a week, 3 sets of 8 to 12 repetitions at 80% to 85% of maximum strength16 weeksn = 28
Cardiac rehabilitation improves Short Physical Performance Battery in humans after CVD hospitalization (mean difference 0.8 (95% CI 0.0-1.6)).
“The mean SPPB values at 6 months were 6.3 (SD = 0.3) and 5.5 (SD = 0.2), respectively, with a mean difference of 0.8 (95% CI = 0.0-1.6), favoring the intervention group.”
Beta-hydroxy-beta-methylbutyrate improves Short Physical Performance Battery in humans (combined with multicomponent exercise training in older adults with frailty).
“SPPB total score had significant time effect (Wald χ 2 = 235.867, P < 0.001), group effect (Wald χ 2 = 8.148, P = 0.004), and interaction effect (Wald χ 2 = 13.846, P < 0.001)”
Human trialcombined with multicomponent exercise training in older adults with frailtycalcium HMB3 g/d12 weeksn = 136
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·
Beta-hydroxy-beta-methylbutyrate improves Short Physical Performance Battery in older adults with sarcopenia undergoing resistance training (2.2, 95 %CI 0.4 to 4.0).
“the intervention group showed significant improvements in SPPB-Balance (1.3, 95 %CI 0.3 to 2.4) and total SPPB score (2.2, 95 %CI 0.4 to 4.0).”
Human trialin older adults with sarcopenia undergoing resistance trainingCa-HMB3 g/day12 weeks
Physical rehabilitation improves Short Physical Performance Battery in humans (baseline CRP ≥9.9 mg/L; patients hospitalized with heart failure) (+2.4 points (95% CI, 1.8-3.1)).
“Among participants with CRP ≥9.9 mg/L, RI was associated with a +2.4 point (95% CI, 1.8-3.1) greater increase in the short physical performance battery”
Human trialbaseline CRP ≥9.9 mg/L; patients hospitalized with heart failure12 weeks
Physical rehabilitation improves Short Physical Performance Battery in humans (frail patients with acute decompensated heart failure) (2.1 (95% CI, 1.3-2.9)).
“2.6-fold larger improvement in SPPB with intervention among frail patients (2.1; 95% CI, 1.3-2.9) vs prefrail patients (0.8; 95% CI, -0.1 to 1.6; P for interaction = .03)”
Human trialfrail patients with acute decompensated heart failure3 monthsn = 192
Exergaming showed no clear effect on Short Physical Performance Battery in humans (compared to regular activities in day-care centers).
“There were no statistically significant differences in outcomes or costs between the groups at the level of participants with dementia, the ICs or the dyad.”
Human trialcompared to regular activities in day-care centersinteractive cyclingat least twice a week6 monthsn = 112
Cardiovascular rehabilitation improves Short Physical Performance Battery in humans (cardiovascular disease and frailty) (MD 1.20 points, 95% CI 0.54-1.87).
“adjusted/model-based Short Physical Performance Battery (SPPB) (MD 1.20 points, 95% CI 0.54-1.87; k = 2)”
High-protein diet improves Short Physical Performance Battery in humans (hypocaloric diet plus exercise in older males with prediabetes and obesity) (Cohen's d = 0.68 at 6 mo).
“For the SPPB score, the Enhanced Protein group had a greater benefit at both 3 mo (small Cohen's d = 0.23) and at 6 mo (moderate Cohen's d = 0.68).”
Human trialhypocaloric diet plus exercise in older males with prediabetes and obesity1.4 g protein/kg/d1.4 g/kg/d6 momales
Blood flow restriction training improves Short Physical Performance Battery in humans (hospitalized older adults with sarcopenia, compared with resistance training).
“the BFR group demonstrated significantly better outcomes in SPPB score, 6-m gait speed, TUG time, and MBI score than the RT group did (all P < 0.01).”
Human trialhospitalized older adults with sarcopenia, compared with resistance training3 times per week12 weeksn = 40
Hearing intervention showed no clear effect on Short Physical Performance Battery in humans (difference 0.00 SD, 95% CI: -0.14, 0.14).
“hearing intervention did not impact change in SPPB (difference comparing intervention to control = 0.00 standard deviation [SD] units, 95% confidence interval [CI]:-0.14, 0.14)”
Ai-assisted dynamic postural control screening combined with adaptive exercise prescriptions
↑upin humans1
1 study
Ai-assisted dynamic postural control screening combined with adaptive exercise prescriptions improve Short Physical Performance Battery in humans (Cohen d=0.45, 95% CI 0.18-0.72).
“The experimental group demonstrated significantly greater improvements compared with the control group in Short Physical Performance Battery scores (Δ=0.8 vs 0.3; t2003=3.41; P=.001; Cohen d=0.45, 95% CI 0.18-0.72)”
Short Physical Performance Battery was not clearly linked with study-specific mean of SF-36 domain scores in humans (Older adults in Montería, Colombia).
“Handgrip strength and the SPPB were not significantly associated with the study-specific mean of the SF-36 domain scores.”
HumansOlder adults in Montería, Colombia81.9% womensn = 155
Time-dependent predictive discrimination for falls
↑upin humans1
1 study
Short Physical Performance Battery is linked with better time-dependent predictive discrimination for falls in humans (Total SPPB score incorporated into the fall risk assessment model versus baseline model) (AUC 0.761, 0.769, and 0.776 at 20, 40, and 60 days, respectively).
“The model incorporating the total SPPB score showed higher AUC values at 20, 40, and 60 days (0.761, 0.769, and 0.776, respectively) compared with the baseline model.”
HumansTotal SPPB score incorporated into the fall risk assessment model versus baseline model20, 40, and 60 daysn = 428
Short Physical Performance Battery is linked with higher mobility decline detection sensitivity in humans (compared with chronological age classification).
“Functional classification using the SPPB provided greater sensitivity than chronological age in detecting early mobility decline.”
Humanscompared with chronological age classification
Short Physical Performance Battery is linked with better early death prediction in the HMA/VEN group (AUC from 0.659 to 0.804 (p = 0.02)).
“addition of SPPB to the existing treatment-related mortality score model improved the prediction of early death, increasing the area under the receiver operating characteristic curve (AUC) from 0.659 to 0.804 (p = 0.02)”
Short Physical Performance Battery mediates Kansas City Cardiomyopathy Questionnaire in humans (acute decompensated heart failure) (64.1% explained, P<0.001).
“The 3-month improvement in short physical performance battery score explained 64.1% of the improvement in Kansas City Cardiomyopathy Questionnaire (P<0.001).”
Human trialacute decompensated heart failure3 monthsn = 349
JPMA. The Journal of the Pakistan Medical Association·
White matter hyperintensities
→mediatesin humans1
1 study
White matter hyperintensities are linked with Short Physical Performance Battery in humans (association between AF and reduced Short Physical Performance Battery) (B = 0.27; P = .03).
“WMH partially mediated the association between AF and reduced Short Physical Performance Battery (B = 0.27; P = .03)”
Humansassociation between AF and reduced Short Physical Performance Batterybrain
Cerebral small vessel disease was not clearly linked with Short Physical Performance Battery in humans (moderate vs. low cSVD burden).
“Balance and gait measures (Short Physical Performance Battery test score, tandem walking, stepping responses to manual retropulsion) were similar in the two cSVD burden groups”
Asymptomatic carotid artery stenosis is linked with worse Short Physical Performance Battery in humans (9.81 ± 0.37 vs 11.10 ± 0.11).
“participants with ACAS demonstrated worse performance on the SPPB (9.81 ± 0.37) compared to those with no ACAS (11.10 ± 0.11) in the 65-74 years age-group (P < 0.0001).”
Low D3-creatine dilution muscle mass is linked with lower Short Physical Performance Battery in humans.
“low D3Cr muscle mass (but not low DXA lean mass or appendicular lean mass) was associated cross-sectionally with worse Short Physical Performance Battery (SPPB) score”
Age-related hearing loss is linked with worse Short Physical Performance Battery in humans (adjusted for age, sex, education, diabetes, and cardiovascular disease).
“Multiple regression analysis with HL, age, sex, education, diabetes, and cardiovascular disease revealed a significant association between reduced SPPB and HL.”
Humansadjusted for age, sex, education, diabetes, and cardiovascular disease>30 dBn = 100
Short Physical Performance Battery predicts mortality in humans (incremental prognostic value beyond clinical variables and CFS) (AUC 0.704 vs 0.679).
“Adding SPPB to a model including conventional variables plus CFS improved discrimination (AUC 0.704 vs 0.679; P=0.029) and risk reclassification (NRI 0.288, 95% CI 0.092–0.485; P=0.004).”
Humansincremental prognostic value beyond clinical variables and CFSn = 968
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·
Short Physical Performance Battery is linked with a higher risk of mortality in humans (undergoing surgery under anesthesia) (aOR = 2.63, 95% CI, 1.15–6.05, p = 0.023).
“SPPB (aOR = 2.63, 95% CI, 1.15–6.05, p = 0.023) remained independently associated with mortality.”
Short Physical Performance Battery is associated with mortality in humans (hospitalized cardiovascular disease patients) (16.3% lower mortality risk per 1-point increase).
“Each 1-point increase in SPPB and MMSE scores correlated with a 16.3% and 8.7% reduction in mortality risk, respectively.”
Short Physical Performance Battery predicts mortality in humans (acute decompensated heart failure) (AUC 0.774).
“higher scores were associated with lower all-cause mortality rates for both assessments; similar area under the curves were measured for both (0.774 for SPPB and 0.776 for BBS).”
Short Physical Performance Battery is associated with frailty in humans (hospitalized patients with heart failure).
“poor nutritional status (lower MNA-SF score), impaired physical function (lower SPPB score), and reduced LVEF are important correlates of frailty severity in these patients.”
Short Physical Performance Battery predicts frailty in humans (Cameroon; frailty defined as SOF index > 0) (Threshold = 9; sensitivity 88.9%; specificity 74.9%).
“After determining the best SPPB threshold for diagnosing frailty (threshold = 9, Se = 88.9%, Sp = 74.9%), 47.9% were frail according to the SPPB.”
HumansCameroon; frailty defined as SOF index > 049.6% womensn = 403
Short Physical Performance Battery predicts frailty in humans (Community-dwelling older adults; total SPPB score of 9 points or less) (72.6% diagnostic accuracy).
“The total SPPB score has good diagnostic accuracy to discriminate between nonfrail and frail older adults using a cut-off point of 9 or less”
HumansCommunity-dwelling older adults; total SPPB score of 9 points or lessn = 786
Short Physical Performance Battery predicts frailty in humans (sensitivity/specificity 0.93/0.55 at ≤9, 0.71/0.84 at ≤6, 0.80/0.83 at ≤7).
“Sensitivities/specificities for classifying CHS phenotype, 26- and 34-item frailty indices were 0.93/0.55, 0.71/0.84, and 0.80/0.83 by SPPB cut points of ≤9, ≤6, and ≤7, respectively.”
The journals of gerontology. Series A, Biological sciences and medical sciences·
Short Physical Performance Battery is associated with frailty in humans (elder inpatients in China; multivariate logistic regression) (OR 0.901, 95% CI 0.601–1.350; P<0.001).
“Frailty in elder inpatients in China is characterized by older age, a lower SPPB scores”
Humanselder inpatients in China; multivariate logistic regressionn = 642
Short Physical Performance Battery is associated with frailty in humans (Community-dwelling older adults; SPPB cutoff ≤ 8 points; adjusted analysis) (Adjusted OR 7.44, 95% CI 3.90–14.19).
“The adjusted odds of being frail and being in the frailty process were 7.44 (95% CI = 3.90-14.19) and 2.33 (95% CI = 1.65-3.30), respectively.”
Sao Paulo medical journal = Revista paulista de medicina·
Falls
↓downin humans4↑upin humans4OR 0.758–3.69
8 studies
Short Physical Performance Battery is associated with falls in humans During hospitalization; discharge treated as a competing event (SHR 0.739, 95% CI 0.682–0.800).
“Lower SPPB scores were significantly associated with increased fall risk (SHR: 0.739, 95% CI: 0.682-0.800).”
HumansDuring hospitalization; discharge treated as a competing event60 daysn = 428
Short Physical Performance Battery is associated with sarcopenia in humans (stroke undergoing rehabilitation; multivariable model) (OR 0.83, 95% CI 0.69–0.99).
“lower Short Physical Performance Battery (SPPB) scores (OR = 0.83; 95% CI: 0.69 to 0.99) remained independently associated with sarcopenia.”
Short Physical Performance Battery predicts sarcopenia in humans (β = -0.332, P < .001, AUC = 0.786).
“the SPPB score (β = -0.332, P < .001, area under the receiver operating characteristic curve = 0.786, cutoff = 9.5) and HGS (β = -0.294, P < .001, area under the receiver operating characteristic curve = 0.834, cutoff = 17.75) were the strongest predictors of sarcopenia”
Short Physical Performance Battery predicts physical activity in humans (R2 = 0.573, p = 0.041).
“The models reveal that SPPB provides the most comprehensive value as indicated by a greater R2 value (0.573), and performance on the SPPB predicts physical activity (p=0.041) and fear of falling (p< 0.001).”
Short Physical Performance Battery predicts physical activity in humans.
“Higher baseline Short Physical Performance Battery total scores were associated with higher total weekly minutes of walking and vigorous PA over the follow-up in men and women”
Short Physical Performance Battery is associated with cognitive function in humans (p < 0.05).
“Higher baseline chair stand performance, SPPB scores, and grip strength were significantly associated with more favorable 2-year trajectories in global cognition, memory, and executive function (p < 0.05)”
The journals of gerontology. Series B, Psychological sciences and social sciences·
Test-retest reliability
↑upin humans3
3 studies
Short Physical Performance Battery is associated with test-retest reliability in humans (institutionalized adults with intellectual and developmental disabilities) (ICC = 0.931; p ≤ 0.001).
“The total SPPB score exhibited excellent internal consistency (α = 0.929) and excellent test-retest reliability (ICC = 0.931; p ≤ 0.001)”
Human trialinstitutionalized adults with intellectual and developmental disabilitiesn = 32
Short Physical Performance Battery is associated with test-retest reliability in humans (Testing by two different physiotherapists) (Summary score ICC 0.92).
“both for the total sample (ICC = 0.92, and 0.91 respectively)) and for the subgroup with dementia (ICC = 0.84 and 0.90 respectively).”
HumansTesting by two different physiotherapistsNorwegian versionMean test interval 2.5 daysn = 61
Short Physical Performance Battery is associated with depressive symptoms in humans (Persistent atrial fibrillation; association persisted when IL-6 was included).
“A multivariate analysis model showed that depressive symptoms were directly associated with CHA2DS2-VA (p=0.019), and negatively with SPPB (p<0.001).”
HumansPersistent atrial fibrillation; association persisted when IL-6 was includedwomen: 41.1%sn = 258
Short Physical Performance Battery predicts cardiovascular disease in humans (schizophrenia) (AUC 0.76, 95% CI 0.70-0.82).
“The SPPB score demonstrated the strongest discriminative ability for identifying high cardiovascular risk (area under the curve = 0.76, 95% CI 0.70-0.82).”
Short Physical Performance Battery predicts cardiovascular disease in humans (adding SPPB to traditional CVD risk factors) (ΔC-statistic 0.019 [95% CI, 0.011-0.027]).
“The addition of SPPB to traditional CVD risk factors significantly improved the C-statistics of CVD outcomes (eg, ΔC-statistic 0.019 [95% CI, 0.011-0.027] for composite CVD).”
Humansadding SPPB to traditional CVD risk factorsmedian follow-up of 7.0 yearsn = 5,570
Short Physical Performance Battery is linked with a higher risk of cardiovascular disease in humans (low versus high SPPB score) (HR 1.47 (95% CI, 1.20-1.79)).
“The hazard ratios of composite CVD in low and intermediate versus high SPPB score were 1.47 (95% CI, 1.20-1.79) and 1.25 (95% CI, 1.07-1.46), respectively”
Humanslow versus high SPPB scoremedian follow-up of 7.0 yearsn = 5,570
Short Physical Performance Battery is associated with Performance-Oriented Mobility Assessment in humans (Indian geriatric oncology patients) (Spearman correlation coefficient 0.79).
“a correlation coefficient of 0.79; implies a strong positive association between SPPB and POMA”
Indian Journal of Medical and Paediatric Oncology·
Short Physical Performance Battery is associated with Performance-Oriented Mobility Assessment in humans (solid tumor malignancies) (0.79).
“The correlation between SPPB and POMA was assessed using Spearman's rank correlation method which obtained a correlation coefficient of 0.79 which implies that there is a strong positive association between SPPB and POMA.”
Smart-insole is associated with Short Physical Performance Battery in humans (independent-walking inpatients and outpatients aged 50 or older) (0.831).
“The intraclass correlation coefficient between the total SPPB-SI and SPPB-M scores was 0.831 (p < 0.001)”
Humansindependent-walking inpatients and outpatients aged 50 or oldern = 40
Cardiovascular death or unplanned hospitalization for cardiovascular causes
↓downin humans1HR 0.51
1 study
Short Physical Performance Battery predicts cardiovascular death or unplanned hospitalization for cardiovascular causes in humans after myocardial infarction (HR 0.51, 95% CI 0.32-0.82).
“lower baseline SPPB scores were associated with a significantly higher risk of the primary outcome (HR 0.51, 95% CI 0.32-0.82).”
Human trialafter myocardial infarction1 yearn = 512
Troponin I predicts Short Physical Performance Battery in humans (interaction P=0.040).
“higher cTnI and T were associated with greater 12-week gains in the short physical performance battery and 6-minute walk distance, respectively, among RI participants versus attention control”
Human trial12-week physical rehabilitation intervention vs attention control in patients hospitalized with heart failure12 weeksn = 242
In a 12-week randomized trial, 26 older adults exercised with or without pressure cuffs; the cuff group had greater blood pressure and cholesterol improvements.In a 12-week randomized trial, 26 older adults exercised with or without pressure cuffs; the cuff group had greater blood pressure and cholesterol improvements.